OA08501A - Zwitterionic bicyclic compounds and their salts, solvates, hydrates and esters. - Google Patents

Zwitterionic bicyclic compounds and their salts, solvates, hydrates and esters.

Info

Publication number
OA08501A
OA08501A OA59087A OA59087A OA08501A OA 08501 A OA08501 A OA 08501A OA 59087 A OA59087 A OA 59087A OA 59087 A OA59087 A OA 59087A OA 08501 A OA08501 A OA 08501A
Authority
OA
OAPI
Prior art keywords
esters
solvates
hydrates
salts
bicyclic compounds
Prior art date
Application number
OA59087A
Other languages
English (en)
Inventor
David John Blythin
Ho-Jane Shue
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of OA08501A publication Critical patent/OA08501A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Outer Garments And Coats (AREA)
OA59087A 1985-07-29 1987-03-16 Zwitterionic bicyclic compounds and their salts, solvates, hydrates and esters. OA08501A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/760,196 US4684727A (en) 1985-07-29 1985-07-29 Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents

Publications (1)

Publication Number Publication Date
OA08501A true OA08501A (en) 1988-07-29

Family

ID=25058394

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59087A OA08501A (en) 1985-07-29 1987-03-16 Zwitterionic bicyclic compounds and their salts, solvates, hydrates and esters.

Country Status (23)

Country Link
US (4) US4684727A (xx)
EP (1) EP0232328B1 (xx)
JP (1) JPH0794455B2 (xx)
KR (1) KR900003490B1 (xx)
AT (1) ATE74756T1 (xx)
AU (1) AU597587B2 (xx)
CA (1) CA1263654A (xx)
CZ (1) CZ413991A3 (xx)
DE (1) DE3684903D1 (xx)
DK (1) DK157787A (xx)
FI (1) FI871345A (xx)
HU (1) HU201550B (xx)
IE (1) IE59298B1 (xx)
IL (1) IL79556A (xx)
MX (1) MX9203320A (xx)
MY (1) MY101970A (xx)
NO (1) NO166862C (xx)
NZ (1) NZ217016A (xx)
OA (1) OA08501A (xx)
PH (1) PH23887A (xx)
PT (1) PT83080B (xx)
WO (1) WO1987000752A2 (xx)
ZA (1) ZA865631B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684727A (en) * 1985-07-29 1987-08-04 Schering Corporation Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
US5045542A (en) * 1986-10-20 1991-09-03 Schering Corporation Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives
CA1309658C (en) * 1986-12-05 1992-11-03 David J. Blythin Pharmaceutical compositions for treatment of hyperproliferate skin disease
US5350755A (en) * 1986-12-05 1994-09-27 Schering Corporation Compounds and methods for treating hyperproliferative skin disease
WO1989000571A2 (en) * 1987-07-22 1989-01-26 Schering Corporation Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
US4897487A (en) * 1988-04-06 1990-01-30 Schering Corporation Process for preparing intermediates for pharmaceutically useful bicyclic compounds
US5079360A (en) * 1988-04-06 1992-01-07 Schering Corporation Processes for preparing bicyclic compounds and intermediates thereof
US5180823A (en) * 1988-04-06 1993-01-19 Schering Corporation Processes for preparing bicyclic compounds
US5341575A (en) * 1989-11-01 1994-08-30 Chisum Finis L Apparatus to gather, display, and/or print vehicle chassis measurement data for accurate repair of collision damaged vehicles
US5175151A (en) * 1990-09-07 1992-12-29 Schering Corporation Antiviral compounds and antihypertensive compounds
AU8665991A (en) * 1990-09-07 1992-03-30 Schering Corporation Antiviral compounds and antihypertensive compounds
US5760034A (en) * 1990-11-30 1998-06-02 Schering Corporation Heterocyclic substituted naphthyridinones and methods and compositions employing them
GB9026389D0 (en) * 1990-12-05 1991-01-23 Merck Sharp & Dohme Therapeutic agents
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
JP2683783B2 (ja) * 1992-07-10 1997-12-03 雪印乳業株式会社 シェーグレン症候群治療剤
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
EP1638581A2 (en) * 2003-03-31 2006-03-29 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
WO2007092451A2 (en) 2006-02-06 2007-08-16 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
EP2731617A4 (en) 2011-07-12 2015-07-01 Brigham & Womens Hospital LIPID-CONTAINING PSA COMPOSITIONS, METHODS OF ISOLATION AND METHODS OF USING SAME
JP6918365B2 (ja) 2015-08-19 2021-08-11 プレジデント アンド フェローズ オブ ハーバード カレッジ 脂質化ｐｓａ組成物および方法
CA3030974A1 (en) 2016-07-15 2018-01-18 President And Fellows Of Harvard College Glycolipid compositions and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264602A (en) * 1975-08-15 1981-04-28 Sandoz, Inc. 4-Hydroxy-3-nitro-pyrido[2,3-B]pyridine-2(1H)-ones
FR2469962A1 (fr) * 1979-11-21 1981-05-29 Vallourec Procede et dispositif pour la fabrication d'un tube d'acier sans soudure par laminage a chaud sur mandrin
DE3368929D1 (de) * 1982-04-26 1987-02-12 Schering Corp 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives
US4452800A (en) * 1982-04-26 1984-06-05 Schering Corporation Salts of 3(n-butyl)-4-hydroxy-1-phenyl-1,8-naphthyridine-2(1H)-one and their use in treating chronic obstructive lung diseases
US4628055A (en) * 1982-11-03 1986-12-09 Schering Corporation Method for treating allergic reactions and compositions therefore
US4551463A (en) * 1982-11-03 1985-11-05 Schering Corporation Composition containing 1-phenyl-1,8-naphthridin-2(1H)-ones and a non-steroidal anti-inflammatory drug
US4684727A (en) * 1985-07-29 1987-08-04 Schering Corporation Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents

Also Published As

Publication number Publication date
WO1987000752A3 (en) 1987-05-21
DK157787D0 (da) 1987-03-27
KR900003490B1 (ko) 1990-05-21
NO166862C (no) 1991-09-11
CA1263654A (en) 1989-12-05
CZ413991A3 (en) 1993-01-13
US4684727A (en) 1987-08-04
DK157787A (da) 1987-03-27
ATE74756T1 (de) 1992-05-15
AU597587B2 (en) 1990-06-07
ZA865631B (en) 1987-03-25
JPH0794455B2 (ja) 1995-10-11
EP0232328B1 (en) 1992-04-15
EP0232328A1 (en) 1987-08-19
US4902693A (en) 1990-02-20
US4782067A (en) 1988-11-01
KR870700352A (ko) 1987-12-28
DE3684903D1 (de) 1992-05-21
IE861997L (en) 1987-01-29
HU201550B (en) 1990-11-28
MX9203320A (es) 1992-07-01
NO166862B (no) 1991-06-03
PH23887A (en) 1989-12-18
IL79556A (en) 1995-05-26
NO871311L (no) 1987-03-27
FI871345A0 (fi) 1987-03-27
PT83080A (en) 1986-08-01
JPS63500453A (ja) 1988-02-18
NO871311D0 (no) 1987-03-27
PT83080B (pt) 1989-01-30
HUT42481A (en) 1987-07-28
WO1987000752A2 (en) 1987-02-12
FI871345A (fi) 1987-03-27
US4794116A (en) 1988-12-27
NZ217016A (en) 1989-11-28
MY101970A (en) 1992-02-29
IE59298B1 (en) 1994-02-09
AU6147986A (en) 1987-03-05

Similar Documents

Publication Publication Date Title
ZA865631B (en) Zwitterionic bicyclic compounds and their salts,solvates,hydrates and esters
BG103417A (en) Condensed pyrimidine bicyclic derivatives
PL261349A1 (en) Method of obtaining an incorporative complex of 7-isopropoxyisoflavone with cyclodextrin
IT1205849B (it) Derivati di indolo,procedimenti per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania
HU206701B (en) Process for producing substituted flavonoid derivatives and salts and pharmaceutical compositions containing these compounds
SG48298A1 (en) Saccharin deriatives useful as proteolytic enzymeinhibitors and preparation of
AU3192084A (en) Pharmaceutical compositions of benzothiophene derivatives
HU912013D0 (en) Process for the production of benzopyrane derivatives and their heterocyclic analogues, antiyschemic medical preparations
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
FR2651435B1 (xx)
IL95849A0 (en) Pharmaceutical combination containing acetylsalicylic acid and carbacyclin derivatives
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
AU3760489A (en) Derivatives of cyclic amp as treatment for cancer
GR3005231T3 (xx)
IL66192A (en) Albomycin derivatives,their production and pharmaceutical compositions containing them
HUP9801985A3 (en) Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis
DE3374316D1 (en) Penicillin derivatives
ITMI921125A1 (it) Procedimento per la preparazione di derivati beta-lattamici alogenati
IT1269740B (it) Derivati di combretastatine ad attivita' anti-tumorale e procedimento per la loro preparazione
MX9100344A (es) Procedimientos para la preparacion de derivados de 6-(3-aminopropionilo substituido)-7-desacetilforscolina
IT1243368B (it) Uso del bendazac e dei suoi sali farmaceuticamente accettabili
FR2592653A1 (fr) Derives de chromene, procede d'obtention et compositions pharmaceutiques.